NASDAQ:CNTG
Centogene N.V. Stock News
$0.380
-0.0200 (-5.00%)
At Close: May 16, 2024
CENTOGENE Reports Record Fourth Quarter and Full Year 2020 Financial Results
06:30am, Thursday, 15'th Apr 2021
Delivers very strong financial results in unprecedented year Delivers very strong financial results in unprecedented year
CENTOGENE Extends Partnership With Takeda
06:30am, Wednesday, 14'th Apr 2021
CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, April 14, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical
CENTOGENE to Announce Full Year 2020 Financial Results on April 15, 2021
06:30am, Thursday, 08'th Apr 2021
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, April 08, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clin
CENTOGENE Reaches 10,000 Participant Milestone in Global Parkinson's Disease Study
06:30am, Tuesday, 09'th Mar 2021
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 09, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clini
CENTOGENE Announces Voting Results of Extraordinary General Meeting
10:02am, Friday, 18'th Dec 2020
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“CENTOGENE” or the “Company”), a commercial-stage company focused on rare dis
Centogene N.V. (CNTG) CEO Andrin Oswald on Q3 2020 Results - Earnings Call Transcript
02:58pm, Wednesday, 16'th Dec 2020
Seeking Alpha Transcripts | Healthcare Centogene N.V. (CNTG) CEO Andrin Oswald on Q3 2020 Results - Earnings Call Transcript Dec. 16, 2020 2:58 PM ET | | About: Centogene N.V. (CNTG) by: SA Transcript
Recap: Centogene Q3 Earnings
07:03am, Wednesday, 16'th Dec 2020
Shares of Centogene (NASDAQ:CNTG) remained unaffected in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 97.88% year over year to ($0.30), which
CENTOGENE Reports Third-Quarter 2020 Financial Results and Increases Full Year Guidance
06:30am, Wednesday, 16'th Dec 2020
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“CENTOGENE” or the “Company”), a commercial-stage company focused on rare dis
CENTOGENE to Report Third-Quarter 2020 Financial Results on December 16, 2020
06:30am, Wednesday, 09'th Dec 2020
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clini
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN and MUNICH, Germany, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transfo
CENTOGENE Expands Partnership with PTC Therapeutics to Generate New Insights for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
06:30am, Wednesday, 25'th Nov 2020
Expanded Partnership Provides Free Biochemical and Genetic Testing to Patients Enrolled in REVEAL CP Study and Expands Global No-Cost Testing Program to Additional Countries Expanded Partnership Provi
CENTOGENE Announces Nomination of Jonathan Sheldon to Supervisory Board
11:30am, Friday, 13'th Nov 2020
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 13, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical an
Fujirebio Europe and CENTOGENE Enter Partnership to Provide Rapid and High-Quality Preventive SARS-CoV-2 Antigen Testing
04:00am, Monday, 09'th Nov 2020
GENT, Belgium and CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms
CENTOGENE Opens Walk-In COVID-19 Testing Facility at Berlin Brandenburg Airport
02:00am, Thursday, 05'th Nov 2020
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinic
CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
05:30am, Thursday, 20'th Aug 2020
CAMBRIDGE, Mass. and ROSTOCK, Germany and HAMBURG, Germany and BERLIN, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transfo